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overlapping activities will be identified (Durbec et al.,Catherine L. Keck,§ Drazen B. Zimonjic,§
1996; Jing et al., 1996, Treanor et al., 1996; Trupp et al.,Nicholas C. Popescu,§ Eugene M. Johnson, Jr.,²
1996; Creedon et al., in press).and Jeffrey Milbrandt*
GDNF was originally isolated based on its ability to*Departments of Pathology and Internal Medicine
maintain the survival of embryonic ventral midbrain do-²Departments of Neurology and Molecular
paminergic neurons in vitro (Lin et al., 1993). FurtherBiology and Pharmacology
studies in vivo have supported the role of GDNF as a³Department of Pediatrics
target-derived trophic factor for embryonic and adultWashington University School of Medicine
dopaminergic midbrain neurons (Stromberg et al., 1993;St. Louis, Missouri 63110
Hudson et al., 1995; Tomac et al., 1995), and exogenous§Laboratory of Experimental Carcinogenesis
GDNF treatment has shown protective effects in severalNational Cancer Institute
animal models of Parkinson's disease, a disease inBethesda, Maryland 20892
which midbrain dopaminergic neurons degenerate (re-
viewed by Lindsay, 1995; Gash et al., 1996; Choi-Lund-
berg et al., 1997). GDNF is now known to promote theSummary
survival of a wide variety of neuronal populations in both
the central and peripheral nervous systems (CNS andGlial cell line-derived neurotrophic factor (GDNF) and
PNS). In the PNS, GDNF can promote the survival ofneurturin (NTN) comprise a family of TGF-b-related
several autonomic and sensory neuron populations, cul-neurotrophic factors (TRNs), which have trophic influ-
tured from either chicken or rat embryos, although withences on a variety of neuronal populations. A receptor
a much lower potency than its dopaminotrophic effectscomplex comprised of TrnR1 (GDNFRa) and Ret was
(Buj-Bello et al., 1995; Ebendal et al., 1995; Trupp et al.,recently identified and found to be capable of mediat-
1995; Kotzbauer et al., 1996).ing both GDNF and NTN signaling. We have identified
Using an expression cloning strategy to identify higha novel receptor based on homology to TrnR1, called
affinity binding proteins for GDNF, the first GDNF recep-TrnR2, that is 48% identical to TrnR1, and is located
tor, called GDNF receptor a (GDNFRa), was recentlyon the short arm of chromosome 8. TrnR2 is attached
cloned by two groups (Jing et al., 1996; Treanor et al.,to the cell surface via a GPI-linkage, and can mediate
1996). GDNFRa has no transmembrane domain, and is
both NTN and GDNF signaling through Ret in vitro.
attached to the cell surface via a glycosyl-phosphatidyl-
Fibroblasts expressing TrnR2 and Ret are z30-fold
inositol (GPI) linkage. In a surprising convergence, initi-more sensitive to NTN than to GDNF treatment,
ated by similarities in the phenotypes of Ret and GDNFwhereas those expressing TrnR1 and Ret respond
deficient mice, the signaling component of the GDNF
equivalently to both factors,suggesting the TrnR2±Ret
receptor was concurrently identified as the protein en-
complex acts preferentially as a receptor for NTN.
coded by the proto-oncogene c-ret, a receptor tyrosine
TrnR2 and Ret are expressed in neurons of the supe-
kinase (Durbec et al., 1996; Jing et al., 1996; Treanor et
rior cervical and dorsal root ganglia, and in the adult al., 1996 Trupp et al., 1996). GDNFRa and Ret form a
brain. Comparative analysis of TrnR1, TrnR2, and Ret functional GDNF receptor complex, and are expressed
expression indicates that multiple receptor com- together in the developing nephron, midbrain, and motor
plexes, capable of mediating GDNF and NTN signaling, neurons, all known targets of GDNF action (Treanor et
exist in vivo. al., 1996).
Given the redundancy of NTN and GDNF trophic activ-
Introduction ity in all survival assays performed thus far, we recently
examined whether NTN can use the same receptor com-
The recent discovery of neurturin (NTN) (Kotzbauer et plex as GDNF, and found that NTN can stimulate Ret
al., 1996), a neurotrophic factor related to glial cell line- activation in SCG neurons, and that GDNFRa can func-
derived neurotrophic factor (GDNF), has established the tion as a coreceptor for both NTN and GDNF in vitro
existence of a new family of neurotrophic factors that (Creedon et al., in press). Here, we describe the cloning
are structurally similar to TGF-b, for which we suggest and initial characterization of a second coreceptor for
the name TGF-b-related neurotrophic factors (TRNs). both NTN and GDNF. To name the receptors appropri-
The mature NTN protein is 42% similar to mature GDNF, ately for their ability to function in both GDNF and NTN
and was initially discovered and purified based on its signaling, we will refer to them as TGF-b- related neuro-
ability to maintain the survival of rat superior cervical trophic factor receptors 1 and 2 (TrnR1 and TrnR2),
ganglion (SCG) neurons in culture (Kotzbauer et al., where TrnR1 corresponds to GDNFRa. As described
1996). The full range of NTNs trophic activities is not yet below, TrnR2 is GPI-linked to the cell surface, and is
known, but initial neuronal survival assays have indi- capable of mediating both NTN and GDNF signaling
cated that NTN, like GDNF, supports the survival of through Ret when expressed in fibroblasts. TrnR2±Ret
rat superior cervical, nodose, and dorsal root ganglion expressing fibroblasts are 10- to 30-fold more sensitive
to NTN than to GDNF treatment, whereas TrnR1±Retneurons in vitro (Kotzbauer et al., 1996). With the recent
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expressing fibroblasts respond similarly to both GDNF p12±21. Because TrnR2 is a receptor for the neuro-
trophic factors NTN and GDNF, we searched for neuro-and NTN. TrnR2 and TrnR1 are expressed in both dis-
tinct and overlapping regions of the developing embryo logical diseases which have been genetically mapped
to this locus. A search of the database revealed onlyand the adult. Comparative expression of TrnR1, TrnR2,
and Ret indicates that the actions of NTN and GDNF one such disease, SPG5A, an autosomal recessive form
of spastic paraplegia, localized to the paracentric regioncan be mediated through multiple receptor complexes
in vivo, and that a physiological pairing of ligands and of chromosome 8 (Hentati et al., 1994). Also, an amplifi-
cation event on 8p12 has been observed in some casesreceptors may exist for the TRNs as it does for the
neurotrophins. of breast and ovarian cancer (Imbert et al., 1996).
TrnR2 and RET Comprise a Second FunctionalResults
Receptor Complex for Both NTN and GDNF
To examine the possibility that TrnR2 can form a func-TrnR2 is a TrnR1 Homolog Identified
by Searching the EST Database tional receptor complex with Ret for NTN and/or GDNF,
we generated NIH3T3 fibroblasts (subclone MG87; ZhanTrnR2 was identified by performing a BLAST (Basic local
alignment search tool; Altschul et al., 1990) search of et al., 1987), which stably express either Ret alone or
both Ret and TrnR2. The cells were treated with recom-the dbEST database, using the full-length rat TrnR1
(GDNFRa) protein sequence as a query (Jing et al., 1996; binant GDNF or NTN, and then lysed. The lysates were
immunoprecipitated with an anti-phosphotyrosine anti-Treanor et al., 1996) (accession number U59486). Three
human ESTs were identified, which showed only partial body and analyzed by Western blot using an anti-Ret
antibody (Figure 2A). Fibroblasts expressing only thebut significant homology to rat TrnR1 (H12981, R02135,
W73681). These ESTs were obtained from the WashU- Ret tyrosine kinase showed no Ret phosphorylation after
treatment with either NTN or GDNF at doses rangingMerck EST project and sequenced in their entirety.
Alignment of these sequences indicated that all three from 50±3000 ng/ml (Figure 2A; data not shown). How-
ever, cells which expressed both Ret and TrnR2 showedESTs encoded partial cDNAs of an identical transcript.
The 59 end of the cDNA was obtained by rapid amplifica- a strong band of approximately 170 kDa upon stimula-
tion with either NTN or GDNF at 50 ng/ml, indicatingtion of cDNA ends (RACE) by polymerase chain reaction
(PCR), using human brain and placenta Marathon RACE that Ret was being phosphorylated on tyrosine residues.
Furthermore, pretreatment of the Ret±TrnR2 fibroblastslibraries (Clontech) as templates. Two alternatively
spliced forms were identified in both brain and placenta; with phosphatidylinositol-specific phospholipase C (PI-
PLC), which specifically cleaves GPI-linked proteinsthe shorter form is missing 399 nucleotides of thecoding
sequence from the 59 end of the cDNA. The correspond- from the cell surface, significantly depleted the NTN-
or GDNF-induced phosphorylation of Ret (Figure 2B).ing mouse cDNAs for both the full-length and splice
variant were also obtained by PCR, using a brain cDNA These data indicate that NTN and GDNF are able to
stimulate Ret phosphorylation only if TrnR2 is presenttemplate. The full-length murine cDNA contains a single
long open reading frame (ORF) encoding a protein of to function as a coreceptor. This is analogous to the
previously described requirement of TrnR1 as a core-463 amino acids; the splice variant identified has an
ORF encoding 330 amino acids (Figure 1A). ceptor with Ret for GDNF (Jing et al., 1996; Treanor et
al., 1996) and NTN (Creedon et al., in press) signaling.The protein encoded by the cDNAs, which we have
termed TrnR2, shows significant homology with TrnR1 The level of Ret phosphorylation in the presence of
the coreceptor TrnR2 was dependent upon the concen-(Figure 1B). The predicted protein for TrnR2 contains a
putative signal peptide at the amino terminus (von tration of NTN or GDNF applied (Figure2C). In the TrnR2±
Ret expressing fibroblasts, Ret phosphorylation wasHeinje, 1986), three potential N-linked glycosylation
sites, and has a stretch of 16 carboxyl-terminal hy- clearly observed in response to NTN treatment at 0.3
ng/ml; an equivalent response to GDNF was observeddrophobic amino acids. The presence of the N- and
C-terminal hydrophobic regions indicates that TrnR2 is at 10 ng/ml. Similar results were obtained with multiple
batches of recombinant GDNF and NTN, and with an-potentially a GPI-linked protein (Udenfriend and Kodu-
kula, 1995), as has been demonstrated for the closely other stable TrnR2±Ret transfectant (data not shown).
To further examine the differential dose responsivenessrelated TrnR1 (Jing et al., 1996; Treanor et al., 1996).
Human TrnR2 is 48% identical to human TrnR1 at the to GDNF versus NTN, we compared the dose depen-
dency of the TrnR2±Ret fibroblasts with fibroblastsamino acid level, and shares 30 of 31 cysteine residues
with nearly identical spacing, indicating a conserved expressing Ret and TrnR1 treated with identical recom-
binant NTN or GDNF preparations. We have shown pre-cysteine backbone structure. All features of TrnR2 indi-
cate that it is closely related to TrnR1, suggesting that viously that TrnR1±Ret expressing fibroblasts respond
to both GDNF and NTN stimulation by Ret phosphoryla-it may also interact with the Ret receptor tyrosine kinase
to promote signaling of NTN and/or GDNF. tion (Creedon et al., in press).When Ret±TrnR1-express-
ing fibroblasts were treated with NTN or GDNF, the ex-We isolated a human P1 artificial chromosome (PAC)
genomic clone for TrnR2, and used fluorescence in situ tent of Ret phosphorylation in response to each factor
was equivalent at all doses tested. The observed differ-hybridization (FISH) analysis to determine its chromo-
somal location (Figures 1C and 1D). Hybridization of ence in the dose-response curves of the Ret±TrnR1 and
Ret±TrnR2 fibroblasts to NTN and GDNF suggests thatbiotin or digoxygenin-labeled TrnR2 probes to normal
human chromosomes revealed a symmetrical fluores- there is a difference in the functional affinity of the li-
gands for the two receptor complexes, TrnR1±Ret andcent signal on the short arm of chromosome 8, in region
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Figure 1. Sequence Analysis and Chromosomal Localization of TrnR2
(A) The nucleotide sequence and amino acid translation of mouse TrnR2. The N-terminal signal sequence and C-terminal hydrophobic domain
are underlined, and potential N-linked glycosylation sites are boxed. The region absent in the splice variant is shaded.
(B) Alignment of the human TrnR1 and TrnR2 amino acid sequences. Identical residues are boxed, and shared cysteine residues are shaded.
(C) The chromosomal location of human TrnR2. Biotin and digoxygenin-labeled human TrnR2 probes showed symmetrical labeling of chromo-
some 8p12±21. The human TrnR2 PAC clone used as a probe was isolated and labeled as described in the Experimental Procedures.
(D) The same metaphase as in (C) showing painting after rehybridization with a chromosome 8 specific probe.
Neuron
796
likely correspond to the two splice forms found in brain
while performing RACE PCR to amplify the 59 end of
the TrnR2 cDNA, the shorter of which is missing 399
nucleotides from the coding region (see Figure 1A). Two
different bands were also observed in testis, which were
significantly smaller (z1.5±1.8 kb) than either of the tran-
scripts detected in the brain (z4 kb). One of the smaller
TrnR2 messages in testis may be analogous to a small
TrnR1 mRNA reported which encodes a truncated pro-
tein of 158 amino acids (Treanor et al., 1996). Low level
expression may also be present in the spleen and in the
adrenal. These results indicate that the tissue distribu-
tion of TrnR2 is more limited than that of TrnR1, which
has been detected in liver, kidney, and brain of adult rat
and mouse (Jing et al., 1996).
We focused further expression analysis on known
sites of GDNF and/or NTN action (Figure 4). In situ hy-
bridization analysis showed only low level expression
of TrnR2 in the substantia nigra in the adult mouse,
and in the ventral mesencephalon of an E14 mouse, in
contrast to high level expression of TrnR1 and Ret (Fig-
ure 4A; data not shown). Motor neurons in the ventral
horn of the adult spinal cord also express TrnR1 and
Ret, butnot TrnR2 (Figure 4B). TrnR2 is highly expressed
in the developing and adult dorsal root ganglia (DRG),
along with Ret and TrnR1 (Figure 4C; data not shown).
In the developing kidney and gut, there is high level
expression of TrnR1 and Ret, but not TrnR2 (Figure 4C).
Finally, we observed significant expression of both
TrnR2 and Ret in the rat SCG, with only low level, diffuse
Figure 2. TrnR2 and Ret Comprise a Functional NTN and GDNF staining of TrnR1 (Figure 4D). These data indicate a
Receptor Complex partially overlapping expression pattern for TrnR1 and
(A) Fibroblasts stably transfected with Ret alone (Ret), or both Ret TrnR2 in embryonic and adult central and peripheral
and TrnR2 (Ret±TrnR2), were assayed for Ret phosphorylation by
nervous tissue. In several areas of known GDNF action,immunoprecipitation with anti-phosphotyrosine antibody and im-
including nigral and motor neurons, high levels of TrnR1munoblotting with an anti-Ret antibody (IP). Cells were treated for
and Ret are expressed, with only low or undetectable10 min with 50 ng/ml NTN or GDNF or left untreated (-). Anti-Ret
immunoblot analysis of the corresponding total lysates below illus- levels of TrnR2 expression. Based on this initial survey,
trates equal Ret expression (Total). Two bands are visible in the total TrnR2 expression is largely limited to neuronal tissue in
lysate corresponding to both the immature (150 kDa) intracellular both embryo and adult, with highest levels of expression
protein and the glycosylated mature protein (170 kDa). Only the
in sensory and sympathetic neuronal populations.mature form is immunoprecipitated by the phosphotyrosine anti-
body. Cells expressing both TrnR2 and Ret, but not Ret alone,
responded to NTN and GDNF treatment.
TrnR2 Is Expressed in Newborn Rat SCG Neurons,(B) Phosphatidylinositol-specific phospholipase C (PI-PLC) treat-
ment of Ret±TrnR2 fibroblasts depletes Ret phosphorylation induced a Population Responsive to Both NTN and GDNF
by NTN and GDNF. Ret±TrnR2 fibroblasts were pre-treated with 1 Both NTN and GDNF promote the survival of newborn
U/ml PI-PLC for 45 min, washed twice, and processed as in (A). rat SCG neurons in culture, presumably through their
(C) Dose-response of NTN and GDNF treatment on Ret phosphoryla-
activation of the Ret signaling pathway (Trupp et al.,tion in fibroblasts stably expressing both Ret and TrnR2 (TrnR2±Ret)
1995; Kotzbauer et al., 1996; Creedon et al., in press).or Ret and TrnR1 (TrnR1±Ret). Cells were stimulated with the indi-
As shown in Figure 4D, in situ hybridization analysiscated amount of factor for 6 min, immunoprecipitated, and immu-
noblotted as in (A). indicates that TrnR2 and Ret areexpressed at high levels
in rat SCG neurons, whereas TrnR1 is expressed dif-
fusely and does not appear to be localized to neurons.
TrnR2±Ret. The TrnR2±Ret complex may function pref- To further assess the cellular localization of TrnR1,
erentially as a NTN receptor, whereas the TrnR1±Ret TrnR2, and Ret mRNAs in this ganglion, we analyzed
complex responds equivalently to either factor. their expression in primary SCG cultures by reverse tran-
scription polymerase chain reaction (RT-PCR). Because
the primary cultures contain a small contaminating pop-Expression of TrnR2 Is Observed in the Brain
and Testis of the Adult Mouse, and Shows ulation of nonneuronal cells (Schwann cells and fibro-
blasts), neuronal specific messages were identified byPartial Overlap with TrnR1
Northern analysis of TrnR2 message in adult mouse inducing apoptosis in the neuronal population. Removal
of nerve growth factor (NGF) from the culture mediumtissues revealed expression in brain and testis (Figure
3A). Two messages were observed in brain, differing results in near complete death of the neuronal popula-
tion within 48 hours (Martin et al., 1988; Deckwerth andonly slightly in size (Figures 3A and 6). These two bands
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Figure 3. RNA Blot Analysis of TrnR2 Expres-
sion in Adult Mouse Tissues
Samples of total RNA (25 mg) isolated from
the indicated tissues were loaded into each
lane. A 32P-labeled TrnR2 probe was gener-
ated and hybridized to the blot as described
in the Experimental Procedures. Two TrnR2
mRNA species are visible in the brain. The
28S ribosomal RNA band visualized with
ethidium bromide is shown below to demon-
strate equal loading.
Johnson, 1993; Edwards and Tolkovsky, 1994). During 1987). Because GDNF is up-regulated after injury, and
because TrnR1 is expressed by Schwann cells (Treanorthis period, neuronal messages decrease whereas mes-
sages from nonneuronal cells remain constant (Estus et et al., 1996), we hypothesized that one or both of the
TRN coreceptors might also be up-regulated after tran-al., 1994; Freeman et al., 1994). Reverse transcribed
cDNA libraries were prepared from cultures at multiple section, in a manner analogous to the up-regulation of
p75. We examined the expression of TrnR1 and TrnR2time points between 0 and 36 hr, and PCR was per-
formed to assess the expression of Ret, TrnR1, and in the distal segment of the rat sciatic nerve before and
after transection, using RNA blot analysis (Figure 6).TrnR2 (Figure 5). Ret and TrnR2 messages decreased
as the neurons died, in a manner similar to neuron- Seven days after nerve transection, the distal portion of
the sciatic nerve showed a dramatic increase in thespecific enolase (NSE). In contrast, TrnR1 levels re-
mained constant, similar to the Schwann cell marker level of TrnR1 mRNA. In contrast, TrnR2 mRNA was not
detected in the nerve either before or after transection.S-100. These data indicate that Ret and TrnR2 expres-
sion is largely limited to neurons in neonatal rat SCG Consistent with the observed differential expression of
TrnR1 and TrnR2 in Schwann cells, RT-PCR analysiscultures, and likely mediates the functional response of
these neurons to NTN and GDNF. This is consistent of the JS-1 Schwann cell line also showed expression
of TrnR1, but not TrnR2 (data not shown). These resultswith in situ hybridization analysis (Figure 4D), which also
indicates that the expressed receptor complex in SCG indicate that TrnR2 is unlikely to play a major role in
Schwann cell mediated peripheral trophic support ofneurons consists of TrnR2 and Ret. Interestingly, NTN
is more potent in promoting the survival of SCG neurons the regenerating nerve. However TrnR1, in conjunction
with GDNF produced by the distal sciatic nerve andthan GDNF (Kotzbauer et al., 1996), which is consistent
with the higher sensitivity of the TrnR2±Ret receptor muscle, could potentially provide a potent trophic sub-
strate for growth of the regenerating nerve.complex to NTN treatment (Figure 2C). Although some
low level neuronal expression of TrnR1 cannot be ex-
cluded by this assay, these data indicate that it is pre- Discussion
dominantly expressed in the nonneuronal population,
consistent with its previously observed expression in We have identified, isolated and begun to characterize a
novel receptor for the TGF-b related neurotrophic factorSchwann cells (Treanor et al., 1996; Figure 6).
(TRN) family of ligands, which we have called TrnR2.
Like TrnR1 (GDNFRa), TrnR2 is GPI-linked to the cellTrnR1, but Not TrnR2, Is Up-Regulated in Distal
Sciatic Nerve after Nerve Injury surface, and is able to mediate both NTN and GDNF
signaling through the Ret tyrosine kinase receptor. Pre-GDNF is a well-characterized trophic factor for both
embryonic and adult motor neurons (Henderson et al., sumably a complex of Ret, TrnR2, and ligand is formed
which initiates Ret dimerization and autophosphoryla-1994; Li et al, 1995; Oppenheim et al., 1995; Yan et al.,
1995). In the adult animal, GDNF expression is up-regu- tion, although further experiments will be necessary to
determine both the exact kinetics and the stoichiometrylated in the distal segment of the sciatic nerve after
transection and in denervated muscle (Springer et al., of this complex. Our data concur with those of others,
which indicate that Ret alone is insufficient for NTN and1995; Trupp et al., 1995). This is similar to observations
regarding NGF and the p75 low affinity neurotrophin GDNF signaling, and that a coreceptor is necessary (Jing
et al., 1996; Treanor et al., 1996; Creedon et al., in press).receptor (p75NTR), which are both upregulated by
Schwann cells in the distal segment of the sciatic nerve Because NTN and GDNF are able to signal through both
coreceptors, we believe that the TrnR nomenclature isafter transection (Taniuchi et al., 1986; Heumann et al.,
Neuron
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Figure 4. In Situ Hybridization Analysis of TrnR1, TrnR2, and Ret in Targets of GDNF and NTN Action
(A) E14 mouse ventral mesencephalon (vm). Strong staining of TrnR1 and Ret are observed in the developing ventral mesencephalon, with
low levels of TrnR2 transcripts detected.
(B) Adult mouse spinal cord. TrnR1 and Ret are expressed in large motor neurons of the ventral horn (vh), whereas TrnR2 is not. Ret is
localized predominately to motor neurons, whereas TrnR1 shows additional staining in the intermediate and dorsal horns of the cord.
(C) E14 mouse kidney, gut, and dorsal root ganglia. Strong expression of TrnR1 and Ret, but not TrnR2, is visible in the developing kidney
(k) and gut (g). In both kidney and gut, TrnR1 staining is stronger, and more diffuse than Ret. TrnR1, TrnR2, and Ret are all expressed in the
dorsal root ganglia (drg). In addition, the exiting nerve root (r) shows strong expression of TrnR1 and TrnR2 with no expression of Ret.
(D) TrnR2 and Ret are highly expressed in the adult rat superior cervical ganglion (SCG). Diffuse, low level TrnR1 expression was also observed.
more appropriate than the previous GDNFR nomencla- equivalently to stimulation with either ligand at all doses
tested. Together these results indicate redundancy ex-ture and allows the addition of future members of the
receptor family, without an inappropriately restrictive ists in the signaling ability of both GDNF and NTN
through TrnR1 and TrnR2, and that NTN may preferen-designation based on GDNF or NTN alone.
The TrnR2±Ret receptor complex responded to stimu- tially signal through the TrnR2±Ret receptor complex.
We chose a fibroblast-based model system as opposedlation with ligand in a dose-dependent manner. In
TrnR2±Ret expressing fibroblasts, NTN stimulated Ret to a Ret expressing neuroblastoma (Jing et al., 1996)
because the MG87 fibroblasts do not contain endoge-phosphorylation at an approximately 30-fold lower dos-
age than GDNF. TrnR1±Ret expressing cells responded nous TrnR1 or TrnR2 mRNA as assessed by RT-PCR
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Figure 6. Up-Regulation of TrnR1, but Not TrnR2, in the Distal Seg-
ment of the Sciatic Nerve after Nerve Transection
RNA blot analysis of TrnRs demonstrating expression before and
after nerve injury. Total RNA was prepared from normal rat sciatic
nerve (N), and the distal segment of the sciatic nerve 7 days posttran-
Figure 5. RT-PCR Analysis of Ret, TrnR1, and TrnR2 Expression in section (7D). Brain is included as a positive control for detection of
E21 Rat SCG Cultures TrnR2 message. 32P-labeled TrnR1 and TrnR2 probes were gener-
ated and hybridized to blots as described in the Experimental Proce-SCG neurons from E21 rats were deprived of NGF after 5 days in
dures. The 28S ribosomal RNA band, visualized using ethidium bro-culture. mRNA isolated at 6, 12, 18, 24, and 36 hours after NGF
mide, is shown below to demonstrate equal loading.removal was analyzed by RT-PCR for Ret, TrnR1, and TrnR2. RT-
PCR was performed in the linear range of amplification for all tran-
scripts. Each cDNA preparation was normalized to the level of actin
or interaction with Ret. Of course, to fully understandmessage (not shown). Neuron-specific enolase (NSE) and S-100 are
shown as examples of neuronal and Schwann cell specific markers, the interactions between ligand and receptor in vivo,
respectively. detailed expression analysis and assessment of multiple
biological responses, in the context of both normal mice
and those with null mutations for ligands and receptors,
will be required.analysis (data not shown); therefore, the properties of
defined receptor complexes could be ascertained. We TrnR1 and TrnR2 are expressed in a partially overlap-
ping manner in the adult brain and in the embryo. Inhave found that neuroblastoma lines may express either
TrnR1, TrnR2, or both, and that despite this heterogene- regions where they are coexpressed, such as the DRG
and the brain, more detailed study will be required toity those that respond to GDNF or NTN always respond
to both factors (unpublished data). It is notable that in determine whether TrnR1 and TrnR2 are expressed in
distinct cell populations or are coexpressed in individualseveral ligand±receptor systems in which multiple family
members have been identified, there is evidence of cells. Furthermore, we observed regions that express
TrnR1 and TrnR2 but do not contain detectable levelscross-talk between different ligands and receptors, par-
ticularly in fibroblast-based model systems. The neuro- of Ret (data not shown), indicating that these receptors
may be able to interact with other signal-transducingtrophins BDNF, NT-3, and NT-4/5 areall able tostimulate
phosphorylation of the TrkB receptor expressed in fibro- molecules, may act ina soluble form with Ret, orperhaps
may have additional functions independent of signalblasts, with an equivalent dose-response relationship
(Ip et al., 1993). However, in PC12 cells, BDNF and NT- transduction. When TrnR1 was first identified in a screen
for high affinity GDNF binding proteins, it was noted that4/5 stimulate TrkB phosphorylation at 100-fold lower
dosages than NT-3. It is believed that the p75NTR may Ret and TrnR1 are expressed in most targets of known
GDNF action, including embryonic and adult nigra, mo-play a role in the restriction of NT-3 binding to TrkB in
PC12 cells and neurons (Ip et al., 1993). Although the tor neurons, gut, and kidney (Treanor et al., 1996). Our
data confirm these observations, and further indicateefficiency of the interaction is disputed, there is also
evidence that NT-3 can signal through TrkA (Cordon- that TrnR2 is expressed at low levels or not at all in
these regions, in both the E14 embryo and adult mouse.Cardo et al., 1991; Ip et al., 1993), and, furthermore, that
different splice forms of TrkA interact differentially with We have also shown that TrnR1 appears to be up-regu-
lated by Schwann cells in response to nerve injury inNT-3 but identically with NGF (Clary and Reichardt,
1994). Therefore, although in vitro model systems are conjunction with GDNF, whereas TrnR2 is not. In con-
trast, TrnR2 and Ret appear to comprise the expresseduseful, they obviously cannot recreate theneuronal envi-
ronment in vivo, which may include additional accessory receptor complex in SCG neurons, whereas low levels
of TrnR1 mRNA are present in the nonneuronal cells offactors and multiple forms of the existing receptor com-
ponents, which can alter specificity. We cannot exclude the ganglion.
NTN was discovered based upon its ability to supportthe possibility that other accessory factors, and splice
variants of both TrnR1 and TrnR2, mayconfer differential the survival of neonatal SCG neurons (Kotzbauer et al.,
1996). GDNF has shown variable survival promotion ofspecificity for GDNF or NTN. Indeed, the splice variant
form of TrnR2 we have found has a large deletion in the cultured SCG neurons from multiple species, with a gen-
erally lower potency than that of its actions on midbraincoding region, which may alter ligand binding properties
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(Applied Biosystems). Sequence editing, mapping, alignment, anddopaminergic neurons (Henderson et al.,1994; Buj-Bello
contigproduction were performedusing the DNAstar software pack-et al., 1995; Ebendal et al., 1995; Trupp et al., 1995). The
age. ESTs were obtained from the WashU-Merck EST project andonly study that directly compared the actions of NTN
sequenced completely. RACE was performed using Klentaq LA PCR
and GDNF on SCG neurons found that NTN was more (Barnes, 1994) and human brain and placenta cDNA libraries, per
potent than GDNF at promoting SCG survival (Kotzbauer manufacturers instructions (Clontech). Products were cloned into
the EcoRV site of pBluescript KS (Stratagene, La Jolla, CA) andet al., 1996). We believe the differential dose-response
sequenced, and a contig was generated of the full-length humanrelationship, and the accumulating data on GDNF, NTN,
cDNA.TrnR1, TrnR2, and Ret expression, together suggest that
For the TrnR2 expression construct, the coding region of the longa physiological pairing of ligand and receptor may exist
form of human TrnR2 cDNA was amplified by Klentaq LA PCR
for the TrnRs as it does for the Trks. It must be noted from the same Marathon RACE human brain library, using primers
that if such a physiological pairing does exist, there is 59-GCGGTACCATGATCTTGGCAAACGTCTGC-39 and 59-GCTCTA
GAGTCAGGCGGCTGTTCTTGTCTGCG-39. The product was clonedalready potential evidence of cross-talk between ligands
into pCMV-neo (Brewer, 1994), and the insert was confirmed byand receptors (Figure 2C). Mice lacking GDNF show a
sequencing. Human and mouse TrnR2 genomic clones were ob-z30% loss of SCG neurons (Moore et al., 1996; Pinchel
tained by screening P1 (mouse) and PAC (human) genomic libraries
et al., 1996; Sanchez et al., 1996), indicating that at some with a PCR assay generated from the TrnR2 coding region (Genome
point in development a subpopulation of SCG neurons Systems, St. Louis, MO). Mouse genomic sequence was used to
are singularly dependent on GDNF trophic support for design primers to amplify the full-length mouse TrnR2 cDNA by
PCR. This fragment was cloned into pBluescript, and the nucleotidesurvival. This may represent signaling of GDNF through
sequence was determined.TrnR2, temporally restricted expression of TrnR1, or the
existence of an as yet unidentified receptor in these
Generation of Fibroblasts Expressing Ret and TrnR2
neurons. or TrnR1
An emerging theme in the expression of TrnR1 is its NIH3T3 fibroblasts (subclone MG87) expressing Ret, Ret±TrnR1,
presence in Schwann cells in the absence of Ret. Ex- and Ret±TrnR2 were generated as described (Creedon et al., in
press). Briefly, fibroblasts were transfected with a Ret-CMV-neopression of TrnR1 without Ret was originally observed
plasmid, selected in 1 mg/ml G418, and screened for Ret expressionby RT-PCR in a Schwann cell line (Treanor et al., 1996).
by Western blotting with an anti-Ret antibody (Santa Cruz). A clonalWe have found the expression of TrnR1, but not TrnR2,
Ret expressing line was used as the parent to generate TrnR1±Ret
in the JS-1 schwannoma line and in adult sciatic nerve. and TrnR2±Ret expressing cells. The TrnR2-CMV-neo (or TrnR1-
Also, no Ret was detected in the spinal nerve root of CMV-Neo) and SV2-HisD (gift from Richard Mulligan) plasmids were
the E14 embryo, whereas both TrnR1 and TrnR2 were cotransfected into a Ret expressing clone, and selected in 2mM
L-Histidinol (Sigma, St. Louis, MO). TrnR2±Ret and TrnR1±Ret ex-detected. Furthermore TrnR1 likely has functional signif-
pressing clones were confirmed by Western (Ret) and Northernicance in peripheral nerve injury in the adult, in that it
(TrnR2/TrnR1) blotting.is clearly up-regulated in distal sciatic nerve after tran-
section. TrnR1 may be functioning to concentrate GDNF Ret Phosphorylation Assays, PI-PLC Treatment
and present it to the regrowing nerve, analogous to NIH3T3 cells were grown in DMEM plus 10% calf serum. Fibroblasts
the proposed role of the p75NTR in the same injury were seeded on 6-well plates, at 2.5 3 105/well, and grown to conflu-
ence. Cells were treated with recombinant NTN and GDNF for 10paradigm (Taniuchi et al., 1986). Presumably the regen-
min. Recombinant factors were prepared as described (Creedon eterating motor, sympathetic, and sensory axons express
al., in press). Cells were then washed twice with cold PBS (Sigma)receptor complexes for GDNF, as they are present in
and lysed in 500 ml immunoprecipitation (IP) buffer (1 mM EDTA,
the ventral horn (TrnR1±Ret), DRG (TrnR1±R2±Ret), and 1mM EGTA, 0.2 mM NaOrthovanadate, 150 mM NaCl, 1% Triton
sympathetic neurons (TrnR2±Ret in the SCG). This may X-100, 0.5% NP-40,0.2mM PMSF, and10mM Tris [pH 7.4]). A portion
represent an efficient mechanism for trophic support of of each sample was removed for assaying total lysates. The re-
maining lysates were incubated with agarose-conjugated anti-phos-the regenerating nerve, with the potent neurotrophic
photyrosine antibody (Calbiochem) for 1 hr at 48C. The immunopre-factor GDNF concentrated and presented to the regen-
cipitate was washed three times with cold IP buffer and solubilizederating nerve, which expresses multiple signaling re-
by boiling in SDS sample buffer for 5 min. Samples were run on
ceptors. 7.5% polyacrylamide gels. Gels were transferred to PVDF (Millipore,
In summary, we have characterized a second core- Bedford, MA) or nitrocellulose membranes and incubated in
ceptor for the TGF-b-related neurotrophic factors, blocking solution (Tris Buffered Saline [TBS: 150 mM NaCl in 50 mM
Tris, pH 7.4] with 0.1% Tween-20, 5% dry milk) for 1 hr at 258C.GDNF and NTN. Initial in vitro functional data and ex-
Blots were then incubated overnight, at 48C, in blocking solutionpression analysis together suggest that NTN is the pre-
containing a 1:300 dilution of anti-Ret antibody (Santa Cruz). Blotsferred ligand for TrnR2. The preferred ligand status of
were washed (3 3 15 min) in blocking solution and then incubated
members of the neurotrophin family (NGF for TrkA, with secondary antibody (1:1000 dilution of alkaline-phosphatase
BDNF and NT-4/5 for TrkB, and NT-3 for TrkC) has been conjugated anti-rabbit antibody [New England Biolabs, Beverly, MA]
determined by the synthesis of multiple experimental in blocking solution) for 1 hr at 258C. Blots were then washed in
blocking solution (3 3 15 min); then in TBS plus 0.1% Tween-20analyses in the context of both normal and null-mutant
(2 3 10 min); and finally in 1mM MgCl2, 10mM NaCl, and 10mM Tris-mice. A similar synthesis of multiple experimental ap-
HCl (pH 9.5; 2 3 10 min). Blots were incubated in CDP-Star (Tropix,proaches will be necessary to determine if GDNF and
Bedford, MA) and exposed to X-ray film. For PI-PLC assays, cells
NTN have a preferred receptor in vivo, and if significant were seeded as above and treated with 1 U/ml PI-PLC (Oxford
cross-talk exists. Glycosystems) for 45±60 min at 378C. The cells were then washed
twice with warm media, treated with factors, and processed as
above.Experimental Procedures
Sequence Analysis, PCR Techniques, Cloning RT-PCR Expression Analysis
mRNA in neuronal cultures was assessed using semiquantitativeAll sequencing was performed on an Applied Biosystems 373 DNA
sequencer using Taq DyeDeoxy Terminator cycle sequencing kits RT-PCR as described in Freeman et al. (1994) and Estus et al. (1994)
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and extensively detailed by Estus (1996). Five-day-old SCG cultures Araki, T., and Milbrandt, J. (1996). Ninjurin, a novel adhesion mole-
cule, is induced by nerve injury and promotes axonal growth. Neuronwere switched to medium containing anti-NGF antibodies for vari-
17, 353±361.ous times. Polyadenylated RNA was isolated from the cultures using
the QuickPrep Micro Kit (Pharmacia, Piscataway, NJ), according to Barnes, W.M. (1994). PCR amplification of up to 35-kb DNA with
the manufacturer's instructions. Half of the poly-A RNA was con- high fidelity and high yield from lambda bacteriophage templates.
verted to cDNA by reverse transcription with Moloney murine leuke- Proc. Natl. Acad. Sci. USA 91, 2216±2220.
mia virus reverse transcriptase, with random hexamers (16 mM) as Brewer, C.B. (1994). Cytomegalovirus plasmid vectors for perma-
primers. cDNA from approximately 150 cells was used in a 50 ml nent lines of polarized epithelial cells. Meth. Cell Biol. 43, 233±245.
PCR reaction. After amplification, the PCR products were separated
Buj-Bello, A., Buchman, V.L., Horton, A., Rosenthal, A., and Davies,
by electrophoresis on 10% polyacrylamide gels, visualized by auto- A.M. (1995). GDNF is an age-specific survival factor for sensory and
radiography of the dried gels, and quantified with a PhosphorImager autonomic neurons. Neuron 15, 821±828.
(Molecular Dynamics, Inc., Sunnyvale, CA). The following primer
Choi-Lundberg, D.L., Lin, Q., Yung-Nien, C., Chiang, Y.L., Hay, C.M.,sets were used to generate the PCR products: mouse Ret forward
Mohajeri, H., Davidson, B.L., and Bohn, M.C. (1997). Dopaminergic59-TGGCACACCTCTGCTCTATG-39 and reverse 59-TGTTCCCAGGA
neurons protected from degeneration by GDNF gene therapy. Sci-ACTGTGGTC-39; TrnR1 forward 59-GCACAGCTACGGGATGCTCTT
ence 275, 838±841.CTG-39 and reverse 59-GTAGTTGGGAGTCATGACTGTGCCAATC-39;
Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNATrnR2 forward 59-AGCCGACGGTGTGGCTCTGCTGG-39 and re-
isolation by acid guanidinium thiocyanate-phenol-chloroform ex-verse 59-CCAGTGTCATCACCACCTGCACG-39.
traction. Anal. Biochem. 162, 156±159.
Clary, D.O., and Reichardt, L.F. (1994). An alternatively spliced formFluorescence In Situ Hybridization Analysis (FISH)
of the nerve growth factor receptor TrkA confers an enhanced re-A 120 kb genomic fragment cloned into a PAC vector labeled with
sponse to neurotrophin 3. Proc. Natl. Acad. Sci. USA 91, 11133±biotin or digoxygenin (Bio-prime BRL, Gaithersburg, MD) was used
11137.for in situ hybridization of human chromosomes derived from metho-
trexate-synchronized normal peripheral lymphocyte cultures. The Cordon-Cardo, C., Tapley, P., Jing, S., Nanduri, V., O'Rourke, E.,
Lamballe, F., Kovary, K., Klein, R., Jones, K.R., Reichardt, L.F., andconditions of hybridization, the detection of hybridization signals,
Barbacid, M. (1991). The trk tyrosine protein kinase mediates thedigital-image acquisition, processing and analysis, and direct fluo-
mitogenic properties of nerve growth factor. Cell 66, 173±183.rescent signal localization on banded chromosomes were per-
formed as described (Zimonjic et al., 1995; Svaren et al., 1996). The Creedon, D.J., Tansey, M.G., Baloh, R.H., Osborne, P.A., Lampe,
majority of metaphases hybridized with the biotin or digoxigenin- P.A., Fahrner, T.J., Heuckeroth, R.O., Milbrandt, J., and Johnson,
labeled genomic TrnR2 probe had specific fluorescent signals at E.M.J. (1997). Neurturin shares receptors and signal transduction
identical sites on both chromatids of the short arm of chromosome pathways with glial cell line±derived neurotrophic factor in sympa-
8. The hybridization signal was localized in 100 metaphases with thetic neurons. Proc. Natl. Acad. Sci. USA, in press.
rhodamine signal on DAPI generated and enhanced G-like banding. Deckwerth, T.L., and Johnson, E.M.J. (1993). Temporal analysis of
Fifty metaphases were analyzed directly with both homologously events associated with programmed cell death (apoptosis) of sym-
labeled probes by imaging of DAPI generated and enhanced G-like pathetic neurons deprived of nerve growth factor. J. Cell Biol. 123,
banding at region 8p12±21. To confirm the identity of chromosomes 1207±1222.
with specific signal, the metaphases were rehybridized with a chro- Durbec, P., Marcos-Gutierrez, C.V., Kilkenny, C., Grigoriou, M., War-
mosome 8 probe. All labeled chromosomes were positive for tiowaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F.,
painting. Saarma, M., Sariola, H., and Pachnis, V. (1996). GDNF signaling
through the Ret receptor tyrosine kinase. Nature 381, 789±793.
Expression Analysis by Northern Blotting Ebendal, T., Tomac, A., Hoffer, B.J., and Olson, L. (1995). Glial cell
and In Situ Hybridization line-derived neurotrophic factor stimulates fiber formation and sur-
Total RNA was prepared from mouse and rat tissues, and electro- vival in cultured neurons from peripheral autonomic ganglia. J. Neu-
phoresis was performed on 1% agarose/formaldehyde gels and rosci. Res. 40, 276±284.
blotted onto nylon membranes (Zetaprobe) as previously described
Edwards, S.N., and Tolkovsky, A.M. (1994). Characterization of(Chomczynski and Sacchi, 1987). Fragments of the mouse TrnR2
apoptosis in cultured rat sympathetic neurons after nerve growthand rat TrnR1 cDNAs were 32P-labeled and used as hybridization
factor withdrawal. J. Cell Biol. 124, 537±546.probes. Surgical procedures for obtaining rat sciatic nerve samples
Estus, S., Zaks, W.J., Freeman, R.S., Gruda, M., Bravo, R., andwere performed according to NIH guidelines for care and use of
Johnson, E.M., Jr. (1994). Altered gene expression in neurons duringlaboratory animals at Washington University. Sciatic nerves were
programmed cell death: identification of c-jun as necessary for neu-transected and recovered as previously described (Araki and Mil-
ronal apoptosis. J. Cell Biol. 127, 1717±1727.brandt, 1996). In situ hybridization on fresh frozen tissue samples
Freeman, R.S., Estus, S., and Johnson, E.M., Jr. (1994). Analysis ofwas performed as described (Wanaka et al., 1990). Sense and anti-
cell cycle-related gene expression in postmitotic neurons: selectivesense 33P-labeled RNA probes were transcribed from fragments of
induction of cyclin D1 during programmed cell death. Neuron 12,the TrnR1, TrnR2, and Ret cDNAs.
343±355.
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